+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Prostate Cancer Diagnostics Market Global Forecast By Type (Preliminary Screening, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy), End Users, Regions, Company Analysis

  • ID: 5331444
  • Report
  • May 2021
  • Region: Global
  • Renub Research

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • GSK
  • Pfizer
  • Sanofi
Early detection and treatment that improves survival chances is a paradigm in cancer treatment. Cancer, especially prostate cancer, has impacted more to men than women as their percentage was much lesser than men. Our study investigated that, Prostate cancer is the 2nd most common cancer in men across developed countries to date. At the same time incidences rate has also surged over time. According to the report, Global Prostate Cancer Diagnostics Market will be US$ 7.5 Billion by 2027.



In earlier times, prostate cancer has been diagnosed with DRE, i.e Digital Rectal Examination and PSA blood test, most commonly called Prostate-specific antigen and TRUS, known as Transrectal Ultrasound-guided biopsy. TRUS is the golden standard examination to confirm the diagnosis in all clinical circumstances in today's time. The Diagnostics Market Size for Prostate Cancer World over was US$ 1.6 Billion in 2020.

The most important factor of prostate cancer is age and is rare under the age of 40, and its incidence rate would rise with age. Thus, the factors that are fuelling this market growth are the ageing population and the high prevalence rate of prostate cancer. However, low successes of clinical trials and high costs of drugs are the challenges facing this market. In the year 2019, as per the World Population Ageing report, 703 million people are aged 65 years worldwide. It is expected to get doubled by 2050 and reach 1.5 Billion. Around the nations, several majors have taken by the government and regulatory bodies to overcome this cancer to enhance the diagnostics options and expand the treatment.

Among regions, the most impacted and higher cases of prostate cancer are the North American region, followed by European and Asia-Pacific regions. COVID-19 pandemic has transformed the market landscape. It has impacted almost every sector across the nations due to restrictions, lockdowns, and bard on transportation. Many surgeries have been postponed because of this pandemic. And as per our study, there would be a surge in this market post-pandemic recovery. As per this research report, Global Prostate Cancer Diagnostics Industry is expected to grow with a double-digit staggering CAGR of 24.69% during 2020-2027.

This latest report “Prostate Cancer Diagnostics Market Global Forecast by Diagnosis Type (Preliminary Screening Test, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy), End Users (Hospitals & Clinics, Diagnostics Centers, Research Institute, Others), Regions - North America & Latin America (United States, Canada, Rest of America), Europe (Norway, Italy, Poland, Germany, United Kingdom, Rest of Europe), Asia (China, India, Rest of Asia), Africa (South Africa, Rest of Africa), Company Analysis (GSK, AstraZeneca, Sanofi, Abbott, Pfizer)" provides a complete analysis of Prostate Cancer Diagnostics Industry”

Diagnosis Type - Market breakup from 5 viewpoints

1. Preliminary Screening Test
2. Confirmatory Test
3. PCA3
4. Trans-rectal Ultrasound
5. Biopsy

End-Users - Market breakup from 4 viewpoints

1. Hospitals& Clinics
2. Diagnostic Centers
3. Research institute
4. Others

Regions - Market breakup by Countries

North America & Latin America
  • United States
  • Canada
  • Rest of America
Europe
  • Norway
  • Italy
  • Poland
  • Germany
  • United Kingdom
  • Rest OF Europe
Asia
  • China
  • India
  • Rest of Asia
Africa
  • South Africa
  • Rest of Africa
All companies have been covered with 3 viewpoints
  • Overviews
  • Recent Developments
  • Revenues
Company Analysis

1. GSK
2. AstraZeneca
3. Sanofi
4. Abbott
5. Pfizer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • AstraZeneca
  • GSK
  • Pfizer
  • Sanofi
1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. Global Prostate Cancer Diagnostic Market

6. Market Share Analysis
6.1 Diagnosis Type
6.2 Confirmatory Test
6.3 End-User
6.4 Regions

7. Diagnosis Type - Global Prostate Cancer Diagnostics Market
7.1 Preliminary Screening Test
7.2 Confirmatory Test
7.3 PCA3
7.4 Trans-rectal Ultrasound
7.5 Biopsy

8. End-User - Global Prostate Cancer Diagnostics Market
8.1 Hospitals & Clinics
8.2 Diagnostic Centers
8.3 Research institute
8.4 Others

9. Regions - Global Prostate Cancer Diagnostics Market
9.1 North America & Latin America
9.1.1 United States
9.1.2 Canada
9.1.3 Rest of America
9.2 Europe
9.2.1 Norway
9.2.2 Italy
9.2.3 Poland
9.2.4 Germany
9.2.5 United Kingdom
9.2.6 Rest OF Europe
9.3 Asia
9.3.1 China
9.3.2 India
9.3.3 Rest of Asia
9.4 Africa
9.4.1 South Africa
9.4.2 Rest of Africa

10. Company Analysis
10.1 GSK
10.1.1 Overviews
10.1.2 Recent Developments
10.1.3 Revenues
10.2 AstraZeneca
10.2.1 Overviews
10.2.2 Recent Developments
10.2.3 Revenues
10.3 Sanofi
10.3.1 Overviews
10.3.2 Recent Developments
10.3.3 Revenues
10.4 Abbott
10.4.1 Overviews
10.4.2 Recent Developments
10.4.3 Revenues
10.5 Pfizer
10.5.1 Overviews
10.5.2 Recent Developments
10.5.3 Revenues

List of Figures:
Figure-01: Global - Global Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-02: Global - Forecast for Global Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-03: Type - Preliminary Screening Test Market (Million US$), 2017 - 2020
Figure-04: Type - Forecast for Preliminary Screening Test Market (Million US$), 2021 - 2027
Figure-05: Type - Confirmatory Test Market (Million US$), 2017 - 2020
Figure-06: Type - Forecast for Confirmatory Test Market (Million US$), 2021 - 2027
Figure-07: Type - PCA3 Test Market (Million US$), 2017 - 2020
Figure-08: Type - Forecast for PCA3 Test Market (Million US$), 2021 - 2027
Figure-09: Type - Trans-rectal Ultrasound Test Market (Million US$), 2017 - 2020
Figure-10: Type - Forecast for Trans-rectal Ultrasound Test Market (Million US$), 2021 - 2027
Figure-11: Type - Biopsy Test Market (Million US$), 2017 - 2020
Figure-12: Type - Forecast for Biopsy Test Market (Million US$), 2021 - 2027
Figure-13: By User - Hospitals& Clinics Market (Million US$), 2017 - 2020
Figure-14: By User - Forecast for Hospitals& Clinics Market (Million US$), 2021 - 2027
Figure-15: By User - Diagnostic Centers Market (Million US$), 2017 - 2020
Figure-16: By User - Forecast for Diagnostic Centers Market (Million US$), 2021 - 2027
Figure-17: By User - Research Institute Market (Million US$), 2017 - 2020
Figure-18: By User - Forecast for Research Institute Market (Million US$), 2021 - 2027
Figure-19: By User - Others Prostate Cancer Market (Million US$), 2017 - 2020
Figure-20: By User - Forecast for Others Prostate Cancer Market (Million US$), 2021 - 2027
Figure-21: By Region - North America & Latin America Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-22: By Region - Forecast for North America & Latin America Prostate Diagnostic Market (Million US$), 2021 - 2027
Figure-23: By Country - United States Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-24: By Region - Forecast for United States Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-25: By Country - Canada Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-26: By Country - Forecast for Canada Prostate CancerDiagnostic Market (Million US$), 2021 - 2027
Figure-27: By Country - Rest of America Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-28: By Country - Forecast for Rest of America Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-29: By Region - Europe Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-30: By Region - Forecast for Europe Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-31: By Country - Norway Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-32: By Country - Forecast for Norway Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-33: By Country - Italy Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-34: By Country - Forecast for Italy Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-35: By Country - Poland Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-36: By Country - Forecast for Poland Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-37: By Country - Germany Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-38: By Country - Forecast for Germany Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-39: By Country - United Kingdom Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-40: By Country - Forecast for United Kingdom Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-41: By Country - Rest of Europe Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-42: By Country - Forecast for Rest of Europe Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-43: By Region - Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-44: By Region - Forecast for Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-45: By Country - China Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-46: By Country - Forecast for China Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-47: By Country - India Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-48: By Country - Forecast for India Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-49: By Country - Rest of Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-50: By Country - Forecast for Rest of Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-51: By Region - Africa Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-52: By Region - Forecast for Africa Prostate Diagnostic Market (Million US$), 2021 - 2027
Figure-53: By Country - South Africa Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-54: By Country - Forecast for South Africa Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-55: By Country - Rest of Africa Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020
Figure-56: By Country - Forecast for Rest of Africa Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027
Figure-57: GSK - Global Revenue (Million US$), 2015 - 2020
Figure-58: GSK - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-59: AstraZeneca - Global Revenue (Million US$), 2015 - 2020
Figure-60: AstraZeneca - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-61: Sanofi - Global Revenue (Million US$), 2015 - 2020
Figure-62: Sanofi - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-63: Abbott - Global Revenue (Million US$), 2015 - 2020
Figure-64: Abbott - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-65: Pfizer - Global Revenue (Million US$), 2015 - 2020
Figure-66: Pfizer - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-67: Siemens Healthcare GMBH - Global Revenue (Million US$), 2015 - 2020
Figure-68: Siemens Healthcare GMBH - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-69: BioMérieux - Global Revenue (Million US$), 2015 - 2020
Figure-70: BioMérieux - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-71: Hologic, Inc - Global Revenue (Million US$), 2015 - 2020
Figure-72: Hologic, Inc - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-73: MDX Healthcare - Global Revenue (Million US$), 2015 - 2020
Figure-74: MDX Healthcare - Forecast for Global Revenue (Million US$), 2021 - 2027
Figure-75: Myriad Genetics - Global Revenue (Million US$), 2015 - 2020
Figure-76: Myriad Genetics - Forecast for Global Revenue (Million US$), 2021 - 2027

List of Tables:
Table-01: Global - Prostate Cancer Diagnosis Market Share by Type (Percent), 2017 - 2020
Table-02: Global - Forecast For Prostate Cancer Diagnosis Market Share by Type (Percent), 2021 - 2027
Table-03: Global - Prostate Cancer Diagnosis Market Share by Confirmatory Test Type (Percent), 2017 - 2020
Table-04: Global - Forecast For Prostate Cancer Diagnosis Market Share by Confirmatory Test Type (Percent), 2021 - 2027
Table-05: Global - Prostate Cancer Diagnosis Market Share by Regions (Percent), 2017 - 2020
Table-06: Global - Forecast for Prostate Cancer Diagnosis Market Share by Regions (Percent), 2021 - 2027
Note: Product cover images may vary from those shown
  • GSK
  • AstraZeneca
  • Sanofi
  • Abbott
  • Pfizer
Note: Product cover images may vary from those shown

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll